165 related articles for article (PubMed ID: 37699004)
21. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
[TBL] [Abstract][Full Text] [Related]
22. A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area.
Wen D; Shan B; Wang S; Zhang L; Wei L; Zhou W; Peng Q
Eur J Med Genet; 2010; 53(5):250-5. PubMed ID: 20603233
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
24. Signet-ring cell carcinoma in gastric biopsies: expecting the unexpected.
Golembeski CP; Genta RM
J Clin Pathol; 2013 Feb; 66(2):136-9. PubMed ID: 23212932
[TBL] [Abstract][Full Text] [Related]
25. Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.
Bang YJ; Kang YK; Catenacci DV; Muro K; Fuchs CS; Geva R; Hara H; Golan T; Garrido M; Jalal SI; Borg C; Doi T; Yoon HH; Savage MJ; Wang J; Dalal RP; Shah S; Wainberg ZA; Chung HC
Gastric Cancer; 2019 Jul; 22(4):828-837. PubMed ID: 30911859
[TBL] [Abstract][Full Text] [Related]
26. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
27. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.
van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; Barbour AP
Ann Surg Oncol; 2019 Aug; 26(8):2375-2384. PubMed ID: 30941657
[TBL] [Abstract][Full Text] [Related]
29. Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.
Walther C; Zilling T; Perfekt R; Möller T
Eur J Surg; 2001 Oct; 167(10):748-57. PubMed ID: 11775726
[TBL] [Abstract][Full Text] [Related]
30. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
32. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
Hartman DJ; Nikiforova MN; Chang DT; Chu E; Bahary N; Brand RE; Zureikat AH; Zeh HJ; Choudry H; Pai RK
Am J Surg Pathol; 2013 Jul; 37(7):969-77. PubMed ID: 23681075
[TBL] [Abstract][Full Text] [Related]
33. Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
Yoon JY; Brezden-Masley C; Streutker CJ
BMC Cancer; 2020 Sep; 20(1):860. PubMed ID: 32894084
[TBL] [Abstract][Full Text] [Related]
34. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
[TBL] [Abstract][Full Text] [Related]
35. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.
Velanovich V; Hollingsworth J; Suresh P; Ben-Menachem T
Dig Surg; 2002; 19(5):349-53. PubMed ID: 12435904
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
37. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
39.
Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
[TBL] [Abstract][Full Text] [Related]
40. Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas.
Fassan M; Ludwig K; Pizzi M; Castoro C; Guzzardo V; Balistreri M; Zaninotto G; Ruol A; Giacomelli L; Ancona E; Rugge M
Hum Pathol; 2012 Aug; 43(8):1206-12. PubMed ID: 22217477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
